PhD Founder Brief

Global intelligence for PhD founders β€” what’s shifting in research, capital, and talent, and what it means for your venture.

The world of research commercialization doesn’t stand still.

University IP policies are shifting. Deep-tech investment is concentrating in specific sectors and geographies. Talent mobility is reshaping who builds founding teams and where. Sovereign research funds are changing the non-dilutive funding landscape in ways most PhD founders haven’t mapped yet.

If you’re building a venture from your research, these shifts aren’t background noise. They’re the terrain you’re operating in.

The PhD Founder Brief tracks what’s moving globally β€” in research funding, IP reform, capital flows, and talent dynamics β€” and translates it into one practical insight per week for doctoral entrepreneurs.

Not a trend report. Not generic startup advice. Global intelligence, focused on what actually matters for PhD founders building right now.

Five Content Pillars

  • IP & Tech Transfer Policy β€” university negotiations and regional IP reform
  • Deep-Tech Capital Flows β€” where VC and sovereign funding is moving
  • Talent & Team Dynamics β€” co-founder markets and doctoral mobility
  • Research Commercialization Models β€” what’s working across US, EU, Asia
  • Funding Landscapes β€” SBIR, Horizon Europe, non-dilutive capital shifts

Who Writes this?

Todd Maurer β€” founder of Edunomix, owner of VersatilePhD, and 25-year practitioner at the intersection of doctoral expertise and venture strategy across emerging markets, deep tech, edtech, health tech and research commercialization.

How Each Issue Is Structured

Each newsletter issue uses a three-part format:

01🌐  THE GLOBAL SIGNAL One macro trend shaping research commercialization β€” a policy shift, a capital move, a talent dynamic, a funding change.
02πŸ”¬Β  WHAT IT MEANS FOR PhD FOUNDERS The practical implication for someone commercializing research right now. Not commentary β€” translation.
03βœ…Β  ONE ACTION A concrete step you can take this week based on the signal. Specific, not generic.

Read the latest issue β†’ edunomix.substack.com

Trusted by PhD and MD professionals from the VersatilePhD community, a global network of over 120,000 PhD-trained professionals.

One insight per week. No spam. Unsubscribe anytime.